INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,240 | -23.2% | 2,000 | -1.0% | 0.01% | -27.3% |
| Q2 2023 | $82,376 | +9.4% | 2,020 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $75,285 | -23.5% | 2,020 | -28.4% | 0.01% | -26.7% |
| Q4 2022 | $98,390 | -45.3% | 2,820 | -12.4% | 0.02% | -50.0% |
| Q3 2022 | $180,000 | +7.8% | 3,220 | 0.0% | 0.03% | +11.1% |
| Q2 2022 | $167,000 | -28.6% | 3,220 | 0.0% | 0.03% | -12.9% |
| Q1 2022 | $234,000 | -61.7% | 3,220 | -37.7% | 0.03% | -59.7% |
| Q4 2021 | $611,000 | -29.0% | 5,170 | -19.3% | 0.08% | -34.2% |
| Q3 2021 | $860,000 | +343.3% | 6,410 | +434.2% | 0.12% | +350.0% |
| Q2 2021 | $194,000 | +708.3% | 1,200 | +300.0% | 0.03% | +550.0% |
| Q1 2021 | $24,000 | +242.9% | 300 | -40.0% | 0.00% | +100.0% |
| Q4 2019 | $7,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 572,950 | $19,990,226 | 5.79% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $39,952,225 | 5.34% |
| MPM BioImpact LLC | 455,238 | $15,883,254 | 4.12% |
| ARK Investment Management | 9,420,782 | $328,691,084 | 2.85% |
| Atlas Venture Associates IX, LLC | 10,000 | $348,900 | 1.74% |
| Ghisallo Capital Management LLC | 250,000 | $8,722,500 | 1.55% |
| Nikko Asset Management Americas, Inc. | 2,976,002 | $103,743,430 | 1.49% |
| Prosight Management, LP | 72,116 | $2,516,127 | 1.37% |
| Rokos Capital Management LLP | 826,063 | $28,391,785 | 1.24% |
| Elmwood Wealth Management, Inc. | 67,899 | $2,368,996 | 1.18% |